一个神秘的口袋在CB1驱动外围和功能选择性

Vipin Ashok Rangari1,2, Evan S O'Brien3,4, Alexander S Powers3,5,6,7

  • 1Center for Clinical Pharmacology, University of Health Sciences and Pharmacy and Washington University School of Medicine, St. Louis, MO, USA.

Nature
|March 5, 2025
PubMed
概括

通过向外围受体,减少副作用和耐受性,新的大麻素受体1型 (CB1) 激动剂提供更安全的慢性疼痛缓解. 这种方法可以彻底改变疼痛治疗.